EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/12/2025
Back to search
Official data from USPTO
AMARAN BIOTECH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
62
Latest update
05/17/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 42
Filing date
04/02/2015
Registration date
12/03/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2025
Last transaction
05/17/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/09/2019
First use in commerce
09/09/2019
Drawing code
3
Owner type
03
Owner location
Zhubei City, TW
Examiner
WILKE, JOHN
Current location
Historical data usage
Mark description
The mark consists of the words "AMARAN" in black and "BIOTECH" below in gray, with the letter "A" formed by a red, orange, yellow, green and blue arch, and crossing the "A" is a green leaf with a dark green tip.
Holders and representatives
Holders
AMARAN BIOTECHNOLOGY, INC.
AMARAN BIOTECHNOLOGY, INC.
Representatives
John M. Mueller BAKER & HOSTETLER LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugs for medical purposesfor the treatment of cancers; medicines for human purposesfor the treatment of cancers; vaccines for immunization against cancers; Immunomodulatory drug; Anticancer agent; Drug for breast cancer; Drugs for clinical trials for the treatment of cancers; diagnostic preparations for medical purposesfor the treatment of cancers; Active pharmaceutical ingredient for drugs for the treatment of cancers; biological preparations for medical purposesfor the treatment of cancers; chemical preparations for pharmaceutical purposesfor the treatment of cancers; chemical preparations for medical purposesfor the treatment of cancers; chemical reagents for medical or veterinary purposesfor the treatment of cancers; chemico-pharmaceutical preparations for the treatment of cancers; enzyme preparations for medical purposes; enzymes for medical purposes; ferments for pharmaceutical purposes; all of the foregoing offered on a contract manufacturing basis to others
Class 42
Biological research; Bacteriological research; Clinical Researchconducting clinical trials for others; Chemical Analysis; all of the foregoing offered on a contract manufacturing basis to others and limited to research and analysis concerning the treatment of cancers
Publications
History of USPTO decisions and trademark events.
62 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/12/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/12/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/28/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/28/2025
E815
TEAS SECTION 8 & 15 RECEIVED
01/10/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/30/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/29/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/23/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/23/2019
IUAF
USE AMENDMENT FILED
10/03/2019
EISU
TEAS STATEMENT OF USE RECEIVED
10/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/09/2019
EX2G
SOU EXTENSION 2 GRANTED
08/07/2019
EXT2
SOU EXTENSION 2 FILED
08/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
08/07/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/08/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/08/2019
EX1G
SOU EXTENSION 1 GRANTED
02/06/2019
EXT1
SOU EXTENSION 1 FILED
02/06/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/06/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/07/2018
TMBN
TTAB RELEASE CASE TO TRADEMARKS
06/25/2018
OP.T
OPPOSITION TERMINATED NO. 999999
06/25/2018
OP.D
OPPOSITION DISMISSED NO. 999999
06/25/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/23/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/26/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/27/2016
OP.I
OPPOSITION INSTITUTED NO. 999999
08/24/2016
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/26/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/26/2016
PUBO
PUBLISHED FOR OPPOSITION
04/26/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/24/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/22/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
03/22/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/22/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
03/22/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/22/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/21/2016
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/02/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/15/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/14/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/12/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/12/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/12/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/13/2015
GNRT
NON-FINAL ACTION E-MAILED
07/13/2015
CNRT
NON-FINAL ACTION WRITTEN
07/13/2015
DOCK
ASSIGNED TO EXAMINER
07/09/2015
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
04/30/2015
ALIE
ASSIGNED TO LIE
04/28/2015
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/23/2015
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/14/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/13/2015
NWAP
NEW APPLICATION ENTERED
04/06/2015
Continuous trademark protection
Get notified about every new filing that threatens AMARAN BIOTECH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.